#1 HbA1c
Insulin Delivery Systems → HbA1c
Evidence Intelligence™
- EvidenceScore™
- 88
- Strong
- ImpactScore™
- 88
- Very Positive
- ConsistencyScore™
- 88
- consistent
Supporting studies: Based on 17 studies
Explore evidenceDevices & Technology
Diabetes devices, digital tools, monitoring hardware, and therapeutic technology. Use examples: CGM, pumps, closed-loop systems, telehealth tools, monitoring devices
Last updated: August 29, 2026
Key takeaway
Devices & Technology has evidence across 10 diabetes-related outcomes, with strongest support for HbA1c, CGM Time in Range and Hypoglycemia.
Evidence status
Moderate ResearchEvidence Strength: 61/100
Related Evidence Topics
Evidence Intelligence™
Every evidence topic is generated from structured relationships across diabetes research, including topics, interventions, outcomes, and individual studies.
445
Evidence relationships
546
Studies reviewed
23
Outcomes evaluated
Strongest evidence area
HbA1c
Top Interventions
Showing grouped evidence. Expand in Evidence Explorer for detailed intervention-outcome pairs.Open Evidence Explorer
| Rank | Outcome group | EvidenceScore™ | ImpactScore™ | Consistency | Studies | Effectiveness | Action |
|---|---|---|---|---|---|---|---|
| #1 | HbA1c | 88/100Strong | 88/100Very Positive | 88/100consistent | 17 | strong_positive | Explore evidence |
| #2 | CGM Time in Range | 88/100Strong | 69/100Positive | 35/100mixed | 27 | moderate_positive | Explore evidence |
| #3 | Hypoglycemia | 87/100Strong | 56/100Slightly Positive | 56/100generally_consistent | 9 | weak_positive | Explore evidence |
| #4 | Quality of Life Outcomes | 86/100Strong | 59/100Slightly Positive | 35/100mixed | 8 | weak_positive | Explore evidence |
| #5 | Glucose Variability | 84/100Strong | 58/100Slightly Positive | 67/100generally_consistent | 6 | weak_positive | Explore evidence |
| #6 | Body Mass Index | 84/100Strong | 80/100Positive | 60/100generally_consistent | 5 | moderate_positive | Explore evidence |
| #7 | Body Weight | 83/100Strong | 100/100Very Positive | 100/100consistent | 7 | strong_positive | Explore evidence |
| #8 | Fasting Glucose | 83/100Strong | 83/100Positive | 100/100consistent | 6 | moderate_positive | Explore evidence |
| #9 | HbA1c | 83/100Strong | 100/100Very Positive | 100/100consistent | 5 | strong_positive | Explore evidence |
| #10 | Sleep Outcomes | 83/100Strong | 55/100Slightly Positive | 60/100generally_consistent | 5 | weak_positive | Explore evidence |
#2 CGM Time in Range
Insulin Delivery Systems → CGM Time in Range
Evidence Intelligence™
- EvidenceScore™
- 88
- Strong
- ImpactScore™
- 69
- Positive
- ConsistencyScore™
- 35
- mixed
Supporting studies: Based on 27 studies
Explore evidence#3 Hypoglycemia
Insulin Delivery Systems → Hypoglycemia
Evidence Intelligence™
- EvidenceScore™
- 87
- Strong
- ImpactScore™
- 56
- Slightly Positive
- ConsistencyScore™
- 56
- generally_consistent
Supporting studies: Based on 9 studies
Explore evidence#4 Quality of Life Outcomes
Insulin Delivery Systems → Quality of Life Outcomes
Evidence Intelligence™
- EvidenceScore™
- 86
- Strong
- ImpactScore™
- 59
- Slightly Positive
- ConsistencyScore™
- 35
- mixed
Supporting studies: Based on 8 studies
Explore evidence#5 Glucose Variability
Insulin Delivery Systems → Glucose Variability
Evidence Intelligence™
- EvidenceScore™
- 84
- Strong
- ImpactScore™
- 58
- Slightly Positive
- ConsistencyScore™
- 67
- generally_consistent
Supporting studies: Based on 6 studies
Explore evidence#6 Body Mass Index
Digital Lifestyle Interventions → Body Mass Index
Evidence Intelligence™
- EvidenceScore™
- 84
- Strong
- ImpactScore™
- 80
- Positive
- ConsistencyScore™
- 60
- generally_consistent
Supporting studies: Based on 5 studies
Explore evidence#7 Body Weight
Digital Lifestyle Interventions → Body Weight
Evidence Intelligence™
- EvidenceScore™
- 83
- Strong
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- 100
- consistent
Supporting studies: Based on 7 studies
Explore evidence#8 Fasting Glucose
Insulin Delivery Systems → Fasting Glucose
Evidence Intelligence™
- EvidenceScore™
- 83
- Strong
- ImpactScore™
- 83
- Positive
- ConsistencyScore™
- 100
- consistent
Supporting studies: Based on 6 studies
Explore evidence#9 HbA1c
Digital Lifestyle Interventions → HbA1c
Evidence Intelligence™
- EvidenceScore™
- 83
- Strong
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- 100
- consistent
Supporting studies: Based on 5 studies
Explore evidence#10 Sleep Outcomes
Insulin Delivery Systems → Sleep Outcomes
Evidence Intelligence™
- EvidenceScore™
- 83
- Strong
- ImpactScore™
- 55
- Slightly Positive
- ConsistencyScore™
- 60
- generally_consistent
Supporting studies: Based on 5 studies
Explore evidencePractical Questions
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
Which outcomes have the strongest evidence for Devices & Technology?
evidence strengthStrong Evidence
HbA1c and Time in range have the strongest available evidence signals for Devices & Technology.
ConsistencyScore™: Results are consistent across studies.
Ranked evidence signals
- 1
Time in range
EvidenceScore™ Strong | EvidenceScore™ 87.9 | moderate positive | ConsistencyScore™ Generally Consistent | 24 studies
- 2
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 85.9 | moderate positive | ConsistencyScore™ Consistent | 9 studies
Why this answer: This answer is based on 28 supporting studies with consistent results and a positive effect signal.
Limitations
- Population details are unavailable.
What outcomes does Devices & Technology appear to affect most often?
most studiedEmerging Evidence
HbA1c, Time in range, and Blood glucose are among the most studied areas in relation to Devices & Technology.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Time in range
EvidenceScore™ Strong | EvidenceScore™ 87.9 | moderate positive | ConsistencyScore™ Generally Consistent | 34 studies
- 2
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 85.9 | moderate positive | ConsistencyScore™ Consistent | 41 studies
- 3
Blood glucose
EvidenceScore™ Strong | EvidenceScore™ 79.0 | moderate positive | ConsistencyScore™ Consistent | 14 studies
Why this answer: This answer is based on 66 supporting studies and existing graph evidence signals.
Limitations
- Consistency cannot yet be determined.
- Population details are unavailable.
Where are results mixed or inconsistent for Devices & Technology?
consistency issuesModerate Evidence
Results are mixed or unclear for BMI, Body weight, and Sleep efficiency in relation to Devices & Technology.
ConsistencyScore™: Results are mixed and should be interpreted cautiously.
Evidence caveat: The evidence includes both beneficial and harmful or worsening results.
Ranked evidence signals
- 1
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 79.0 | moderate positive | ConsistencyScore™ Mixed | 5 studies
- 2
Sleep quality
EvidenceScore™ Strong | EvidenceScore™ 79.0 | weak positive | ConsistencyScore™ Mixed | 5 studies
- 3
Glucose variability
EvidenceScore™ Strong | EvidenceScore™ 79.0 | weak positive | ConsistencyScore™ Mixed | 4 studies
Why this answer: This answer is cautious because the available studies report mixed findings.
Limitations
- Population details are unavailable.
Which outcomes need more research for Devices & Technology?
research gapsEmerging Evidence
Body weight, HbA1c, and Pain Intensity Score need more research in relation to Devices & Technology.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Body weight
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
- 2
HbA1c
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
- 3
Pain Intensity Score
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
How does Time in range compare with HbA1c for Devices & Technology?
compareStrong Evidence
HbA1c and Time in range have available evidence for Devices & Technology, but the comparison requires review of the underlying studies.
ConsistencyScore™: Results are consistent across studies.
Ranked evidence signals
- 1
Time in range
EvidenceScore™ Strong | EvidenceScore™ 87.9 | moderate positive | ConsistencyScore™ Generally Consistent | 17 studies
- 2
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 85.9 | moderate positive | ConsistencyScore™ Consistent | 9 studies
Why this answer: This answer is based on 26 supporting studies with consistent results and a positive effect signal.
Limitations
- Population details are unavailable.
Outcomes Influenced by Devices & Technology
Outcomes most commonly studied in relation to devices & technology interventions.
HbA1c Reduction
EvidenceScore™ 64/100
Evidence related to lowering or improving HbA1c/A1C in diabetes management.
47 Studies
Glycemic Control
EvidenceScore™ 63/100
Evidence related to blood glucose control, fasting glucose, postprandial glucose, glucose variability, and time in range.
101 Studies
Weight Loss
EvidenceScore™ 62/100
Evidence related to body weight reduction, BMI improvement, waist circumference, and body composition changes.
25 Studies
Treatment Adherence
EvidenceScore™ 59/100
Evidence related to treatment adherence, medication use, physical activity participation, step count, diet intake, fruit and vegetable intake, and self-care behavior adherence.
12 Studies
Inflammatory and Vascular Markers
EvidenceScore™ 59/100
Evidence related to inflammatory, oxidative stress, endothelial, and vascular biomarkers measured in diabetes studies.
2 Studies
Diabetes distress scores
EvidenceScore™ 69/100
5 Studies
Latest Research
Hybrid closed-loop system improves glycemic control in neonatal diabetes.
Published: February 24, 2026
int-hybrid-closed-loop-system
out-average-glucoseout-glucose-variability
Artificial pancreas may improve glucose control in type 1 diabetes
Published: January 20, 2026
int-hybrid-closed-loop-system
out-blood-glucoseout-hypoglycemia-events
Caloric restriction improves glycemic control
Published: January 1, 2026
int-continuous-glucose-monitoring
out-2-hour-plasma-glucoseout-bmi
Automated insulin-glucagon delivery reduces hypoglycemia risk
Published: January 1, 2026
int-hybrid-closed-loop-system
out-blood-glucoseout-coefficient-of-variation
Daqing Diabetes Prevention Study II
Published: January 1, 2026
int-digital-based-lifestyle-intervention
out-blood-glucoseout-bmi
Smart insulin software improves glycemic control in T2DM patients.
Published: January 1, 2026
int-smart-insulin-dosage-software-app-group
out-blood-glucoseout-glycemia-risk-index
Automated insulin delivery improves glucose management in diabetes with CKD
Published: January 1, 2026
int-continuous-glucose-monitoringint-hybrid-closed-loop-system
out-hospitalization-rateout-hypoglycemia-symptom-score
Education Model Improves Glycemic Control in Type 1 Diabetes
Published: January 1, 2026
int-continuous-glucose-monitoring
out-clarke-scoreout-hba1c
Community pharmacy-led diabetes management improves glycemic control in adults with T2DM
Published: January 1, 2026
int-continuous-glucose-monitoring
out-composite-endpoint-achievementout-hba1c
Glunovo rtCGM improves glycemic control in type 2 diabetes.
Published: January 1, 2026
int-glunovo-rtcgm-system
out-glucose-management-indicator-gmiout-hba1c
Evidence Landscape
Evidence landscape
Each bubble represents an evidence relationship. Position shows effectiveness and EvidenceScoreâ„¢; size reflects study volume.
- Strong evidence
- Moderate evidence
- Limited evidence
Evidence Workspace
Create your evidence workspace
Save evidence topics and organize the research that matters to you.